Combating Substandard and Counterfeit Medicines by Securing the Pharmaceutical Supply Chain:

The Drug Supply Chain Security Act (DSCSA) of 2013

  • Phuong Chi Nam Sophie Le University of Minnesota College of Pharmacy
  • Laurie Grund University of Minnesota College of Pharmacy
  • John Marwa University of Minnesota College of Pharmacy
  • John Otts, Jr University of Minnesota College of Pharmacy
  • Wuraola Ojo University of Minnesota College of Pharmacy
  • Farhia Arab University of Minnesota College of Pharmacy
Keywords: Drug Supply Chain Security Act (DSCSA)

Abstract

On November 27, 2013, President Obama signed into law the Drug Quality Security Act (DQSA). Title II of the DQSA, the Drug Supply Chain Security Act (DSCSA), replaces all existing or future state-wide drug track or trace systems with a new federal drug tracing program that uses pedigrees and product identifiers for verification of the drugs being accepted by the buyer. While the full implementation of the DSCSA is projected to take about ten years from its enactment, both the implementation framework and milestones of the new federal tracing program have been carefully laid out. In this essay, we will explore the current state of the U.S. pharmaceutical supply chain and the imperatives behind the DSCSA. At the crux of this essay is an analysis of the DSCSA implementation plan, its challenges according to feedback from stakeholders, and its potential effectiveness against the entrance of substandard and counterfeit drugs into the U.S. pharmaceutical supply chain.

 

Topic: Student Project

 

 

 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
Published
2018-07-16
Section
Policy